Agenus Inc - Asset Resilience Ratio

Latest as of June 2024: 0.73%

Agenus Inc (AGEN) has an Asset Resilience Ratio of 0.73% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See AGEN net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$2.14 Million

Cash + Short-term Investments

Total Assets

$292.42 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2023)

This chart shows how Agenus Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see AGEN asset base.

Liquid Assets Composition Over Time

This chart breaks down Agenus Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Agenus Inc (AGEN) long-term investment share to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$2.14 Million	0.73%
Total Liquid Assets	$2.14 Million	0.73%

Asset Resilience Insights

Limited Liquidity: Agenus Inc maintains only 0.73% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Agenus Inc Industry Peers by Asset Resilience Ratio

Compare Agenus Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
ALK-Abelló A/S CO:ALK-B	Biotechnology	0.98%
Mirum Pharmaceuticals Inc NASDAQ:MIRM	Biotechnology	6.89%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
BB Biotech AG SW:BION	Biotechnology	92.97%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Beijing Konruns Pharmaceutical Co Ltd SHG:603590	Biotechnology	10.55%

Annual Asset Resilience Ratio for Agenus Inc (2000–2023)

The table below shows the annual Asset Resilience Ratio data for Agenus Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	0.14%	$447.00K	$313.91 Million	-3.41pp
2022-12-31	3.55%	$14.68 Million	$413.56 Million	+0.33pp
2021-12-31	3.22%	$14.99 Million	$465.96 Million	--
2020-12-31	0.00%	$0.00	$214.51 Million	--
2018-12-31	0.00%	$0.00	$136.40 Million	--
2017-12-31	0.00%	$0.00	$138.40 Million	--
2016-12-31	3.18%	$4.99 Million	$156.99 Million	-11.26pp
2015-12-31	14.43%	$34.96 Million	$242.23 Million	-5.03pp
2014-12-31	19.47%	$14.51 Million	$74.53 Million	--
2013-12-31	0.00%	$0.00	$34.84 Million	--
2012-12-31	0.00%	$0.00	$34.67 Million	--
2011-12-31	0.00%	$0.00	$19.81 Million	--
2009-12-31	21.80%	$10.00 Million	$45.87 Million	+4.25pp
2008-12-31	17.55%	$9.99 Million	$56.95 Million	+8.12pp
2007-12-31	9.43%	$4.20 Million	$44.54 Million	-12.33pp
2006-12-31	21.76%	$15.88 Million	$72.95 Million	-5.63pp
2005-12-31	27.39%	$28.53 Million	$104.15 Million	-25.92pp
2004-12-31	53.32%	$70.94 Million	$133.06 Million	+30.28pp
2003-12-31	23.03%	$32.27 Million	$140.08 Million	-5.70pp
2002-12-31	28.74%	$25.60 Million	$89.06 Million	+26.40pp
2000-12-31	2.34%	$3.00 Million	$127.97 Million	--

pp = percentage points

About Agenus Inc

NASDAQ:AGEN USA Biotechnology

Market Cap

$324.97 Million

Market Cap Rank

#14812 Global

#3502 in USA

Share Price

$7.22

Change (1 day)

+0.14%

52-Week Range

$2.77 - $8.36

All Time High

$144.45